Showing results (1131-1140 of 1,505) with videos related to

Sort By:
Pageof 151
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2020
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)Liesbeth J Boersma, Janneke Verloop, Adri C Voogd, et al.
Nature Reviews. Cancer|October 19, 2022
Learning to distinguish progressive and non-progressive ductal carcinoma in situAnna K Casasent, Mathilde M Almekinders, Charlotta Mulder, et al.
Nature|February 16, 2016
Tumour-specific proline vulnerability uncovered by differential ribosome codon readingFabricio Loayza-Puch, Koos Rooijers, Levi C M Buil, et al.
Frontiers in Pharmacology|July 2, 2021
Mildly Increased Renin Expression in the Absence of Kidney Injury in the Murine Transverse Aortic Constriction ModelMarian Wesseling, Eva Mulder, Maike A D Brans, et al.
Stem Cell Reports|April 22, 2014
Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neuronsReinhard Roessler, Sebastien A Smallwood, Jesse V Veenvliet, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 11, 2019
Quantitative Third Harmonic Generation Microscopy for Assessment of Glioma in Human Brain TissueZhiqing Zhang, Jan C de Munck, Niels Verburg, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patientsK F D Kuhlmann, S M M de Castro, J G Wesseling, et al.
Breast Cancer Research and Treatment|August 8, 2019
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort studyGurdeep S Mannu, Emma J Groen, Zhe Wang, et al.
Plos One|September 8, 2012
Short-term erythropoietin treatment does not substantially modulate monocyte transcriptomes of patients with combined heart and renal failureKim E Jie, Karien van der Putten, Sebastiaan Wesseling, et al.
Breast Cancer Research and Treatment|December 4, 2012
SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancerJorma J de Ronde, Esther H Lips, Lennart Mulder, et al.
Pageof 151